These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 33737930)

  • 61. Molecular and cellular basis of depigmentation in vitiligo patients.
    Delmas V; Larue L
    Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The possible role of Wnt/β-catenin signalling in vitiligo treatment.
    Lin X; Meng X; Lin J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2208-2221. PubMed ID: 36912722
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.
    Kroll TM; Bommiasamy H; Boissy RE; Hernandez C; Nickoloff BJ; Mestril R; Caroline Le Poole I
    J Invest Dermatol; 2005 Apr; 124(4):798-806. PubMed ID: 15816839
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel mouse model to evaluate neuropeptide Y-mediated melanocyte pathology.
    Anderson ZT; Mehl J; Corder KM; Dobrunz LE; Harris ML
    Exp Dermatol; 2021 Dec; 30(12):1800-1806. PubMed ID: 34114698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of Regulatory Cell Death in Vitiligo.
    Liu LY; He SJ; Chen Z; Ge M; Lyu CY; Gao D; Yu JP; Cai MH; Yuan JX; Zhang JL
    DNA Cell Biol; 2024 Feb; 43(2):61-73. PubMed ID: 38153369
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic update on vitiligo.
    Sarnoff DS
    J Drugs Dermatol; 2015 Feb; 14(2):109-11. PubMed ID: 25689803
    [No Abstract]   [Full Text] [Related]  

  • 69. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
    Cario-André M; Pain C; Gauthier Y; Taïeb A
    Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
    Birlea SA; Costin GE; Norris DA
    Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activation of the unfolded protein response in vitiligo: the missing link?
    Passeron T; Ortonne JP
    J Invest Dermatol; 2012 Nov; 132(11):2502-4. PubMed ID: 23069909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A New View of Vitiligo: Looking at Normal-Appearing Skin.
    Picardo M; Bastonini E
    J Invest Dermatol; 2015 Jul; 135(7):1713-1714. PubMed ID: 26066890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.
    Das PK; van den Wijngaard RM; Wankowicz-Kalinska A; Le Poole IC
    Trends Immunol; 2001 Mar; 22(3):130-6. PubMed ID: 11286727
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ATP-P2X7-Induced Inflammasome Activation Contributes to Melanocyte Death and CD8
    Ahn Y; Seo J; Lee EJ; Kim JY; Park MY; Hwang S; Almurayshid A; Lim BJ; Yu JW; Oh SH
    J Invest Dermatol; 2020 Sep; 140(9):1794-1804.e4. PubMed ID: 32035094
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic syndrome in vitiligo.
    Pietrzak A; Bartosińska J; Hercogová J; Lotti TM; Chodorowska G
    Dermatol Ther; 2012; 25 Suppl 1():S41-3. PubMed ID: 23237037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?
    Peterson D; King BA
    J Am Acad Dermatol; 2021 Jan; 84(1):e63-e64. PubMed ID: 32891783
    [No Abstract]   [Full Text] [Related]  

  • 78. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vitiligo.
    Kovacs SO
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current remedies for vitiligo.
    Abu Tahir M; Pramod K; Ansari SH; Ali J
    Autoimmun Rev; 2010 May; 9(7):516-20. PubMed ID: 20149899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.